
The Danish drugmaker fell as much as 9% after its Capital Markets Day promised new blockbusters and broader growth but failed to give investors the certainty they wanted beyond Wegovy and Ozempic.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

The Danish drugmaker fell as much as 9% after its Capital Markets Day promised new blockbusters and broader growth but failed to give investors the certainty they wanted beyond Wegovy and Ozempic.

Bill Ackman lost $400 million the last time he bought Netflix and bailed within three months. Now Pershing Square just disclosed a $1 billion position, and the reasons he walked away in 2022 look nothing like the streaming landscape he is walking back into.

Broadcom just posted its ninth straight earnings beat while AI revenue exploded triple digits year-over-year, yet the stock has barely moved in 2026. Something has to give, and our model has a strong opinion on which direction.

While President Donald Trump and Vice President JD Vance call for rapid AI growth and push back on the need for industry regulation, billionaire investor and entrepreneur Mark Cuban has been poring over social media, asking questions about the best...

Shares of major fertilizer producers fell Monday after President Trump said the United States was nearing a deal to purchase potash from Belarus. Nutrien (NYSE:NTR) shares slid over 4% to $73.97, Mosaic Co (NYSE:MOS) fell over 2% to $23.77, Intrepid Potash (NYSE:IPI) dropped over 2% to...

Intuit's Big Bets now drive about 30% of revenues, growing above 30% as AI helps scale tax, money and mid-market businesses.
European equities traded in the US as American depositary receipts started the week higher on Monday

GPC, MGA, TM and F offer dividend yields above 2%, backed by payout ratios below 60% and varied growth drivers amid auto-sector risks.

MRK's Keytruda plus Padcev combo gets CHMP backing as perioperative treatment for eligible patients with resectable muscle-invasive bladder cancer.

Whether it be online shopping or social media, secular forces are propelling consumer internet businesses forward. This influence cuts both ways though because they have high exposure to the ups and downs of consumer spending, and uncertainty surrounding this factor has capped the industry’s returns - over the past six months, its 11.6% gain has lagged the S&P 500 by 4.7 percentage points.
Publishers cite internal testimony as evidence of substitution; Microsoft says the remarks do not resolve fair use.

AI agents are going mainstream, and AMD's processors will likely benefit.
ExxonMobil (XOM) refining upside could offset lost earnings from its Middle East exposure, and the c
Restored electricity has not returned Joliet production while fuel markets remain unusually tight.

Uber's stronger bookings growth, lower P/S multiple and broader global scale underpin its edge in this ride-hailing stock faceoff.

AZN and MRK bring distinct oncology strengths, growth plans, pipeline opportunities and patent-related challenges to the table.

Dell Technologies' AI customer base tops 6,500 as enterprise, sovereign and Neocloud demand fuels record orders and a $95B backlog amid tough competition.
Execution may matter more than another round of discounts

InterDigital's 7.1% dividend hike, record recurring revenues and higher 2026 guidance bolster its investment case despite volatility concerns.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Dell Technologies (DELL) remains the "best athlete" among enterprise hardware companies and is best

Credo's 20.3% monthly slide contrasts with triple-digit revenue growth, but premium valuation, customer concentration and execution risks remain.

Novo Nordisk has come under pressure after a prolonged slide in the share price, and the key issue now is whether the current valuation still lines up with what its earnings can reasonably support. With the stock well off its highs despite regular headlines about obesity drugs, AI partnerships and new therapies, investors are asking if the earnings story and the price tag still match. Over the past 3 years the share price has fallen 51.9%, which puts the spotlight squarely on whether the...

Energy Fuels and MP are expanding U.S. rare-earth supply chains, but differing strategies, costs and earnings trends shape the investment case.

Earlier this month, Critical Metals Corp. outlined detailed plans for its proposed CRML Romania mine-to-metals refinery, including process innovations aimed at maximizing value from the Tanbreez Rare Earth Project in Greenland and reducing tailings to about 1% of feed material. An interesting element of the announcement is the projected transformation of silica from a conventional waste stream into a high-purity product that current modelling suggests could generate very large annual revenue...
A major technology partner could accelerate Einride's biggest ambition

Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027. This large academic investment highlights how Bruker’s advanced NMR platforms are being embedded in...

The cannabis stock has been struggling badly this year, but there could be a catalyst up ahead.

Clean Harbors stock jumps 10.4% in six months as expanding PFAS demand, stronger cash generation and a higher 2026 outlook fuel momentum.

When OpenAI agents attacked Hugging Face and rattled the AI sector, two tech giants barely flinched. Their secret sits inside the architecture powering their most ambitious bets on Siri, Robotaxi, and beyond.
Can we count your visit with Google Analytics? No ads, no profiles. Details